Investor Relations

Investor Relations

Ampio Pharmaceuticals Inc. Tel: 1-720-437-6500
Please use this form to request an investor information pack about Ampio Pharmaceuticals, Inc.

Click here for our stock information

 








Name:
*
Company:
Address 1:
*
Address 2:
City:
*
Country:
*
State:
Province:
Zip or Postal Code:
*
Phone:
*
Fax:
Email:
*
Best time to call:
*
Message:
*
Fields, marked with * are required.

Learn More About:

Premature Ejaculation (PE)

Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.

Diabetic Retinopathy

A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness

Diabetic Nephropathy

A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis

AMPE Stock Quote - delayed
Last Change
AMPE 5.06 Down 0.02 (0.39%)

Ampio News

05/13/2013 | Press Release

Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare Conference

04/25/2013 | Press Release

Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion™ in Osteoarthritis of the Knee

04/02/2013 | Press Release

Ampio Receives FDA Clearance to Initiate Clinical Trial of Ampion™ for the Treatment of Osteoarthritis of the Knee: Patient Treatments have begun.

» See all Ampio news